Anti–tumor necrosis factor α treatment p
✍
Erwin Daniel Brenndörfer; Malin Weiland; Lars Frelin; Emma Derk; Gustaf Ahlén; J
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 654 KB
Tumor necrosis factor a (TNFa) has been implicated in a variety of inflammatory diseases, and anti-TNFa has been shown to improve therapy when added to standard of care in chronic hepatitis C virus (HCV) infection. In addition, patients with chronic HCV have increased serum levels of TNFa and the ma